ArticleCancer chemotherapy and pharmacology2024

Enhanced anticancer synergy of LOM612 in combination with selinexor: FOXO1 nuclear translocation-mediated inhibition of Wnt/β-catenin signaling pathway in breast cancer.

Shengxi Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.